Recently.oach to delay onset of Alzheimer’s diseasescientist are working on a cure for Alzheimer’s disease find it hard to medications that will develop pass through the highly selective blood-brain barrier. That may be why a Tel Aviv University researcher decided to take an alternate route – through the nose.
It is among the world’s top 100 universities in science, biomedical studies and social sciences course and rated one of the world ‘s top 200 universities overall. Internationally recognized for the scope and groundbreaking nature of its research programs, Tel Aviv University consistently produces work with profound implications for the future. Diabetes drug ActosIn July, an FDA Advisory Committee whether the to consider whether the GlaxoSmithKline diabetes drug? Avandia from the market due to concerns it increases the risk of heart attack and stroke.The serum aspartate aminotransferase , serum alanine aminotransferase and lactic dehydrogenase was determined levels. A total of antioxidant capacity , catalase , a total oxidative status , oxidative stress index and myeloperoxidase are measured in liver tissue. In addition, liver tissue histopathology has been evaluated from light microscopy.. Add this experimental study, rats underwent hepatic ischemia of 45 rpm at for 60 min period reperfusion of. Rats are infused immunized intraperitoneally with only 0.9 percent saline solution to the control group.